Factor V Leiden and G20210A prothrombin mutations are risk factors for very early recurrent miscarriage

Reznikoff-Etiévant, 1999, Habitual abortions in 678 healthy patients: investigation and prevention, Hum Reprod, 14, 2106, 10.1093/humrep/14.8.2106 Hellgren, 1995, Resistance to activated protein C as a basis for venous thromboembolism associated with pregnancy and oral contraceptives, Am J Obstet Gynecol, 173, 210, 10.1016/0002-9378(95)90192-2 Dahlbäch, 1993, Familial thrombophilia due to a previously unrecognized mechanism characterised by poor anticoagulant response to activated protein C, prediction of a cofactor to activated protein C, Proc Natl Acad Sci USA, 90, 1004, 10.1073/pnas.90.3.1004 Bertina, 1994, Mutation in blood coagulation factor associated with resistance to activated protein C, Nature, 369, 64, 10.1038/369064a0 Zoller, 1994, Linkage between inherited resistance to activated protein C and Factor V Leiden mutation in venous thrombosis, Lancet, 343, 1536, 10.1016/S0140-6736(94)92940-8 Poort, 1996, A common genetic variation in the 3’-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and increase in venous thrombosis, Blood, 10, 3698, 10.1182/blood.V88.10.3698.bloodjournal88103698 Balach, 1997, First-trimester abortion is not associated with activated protein C resistance, Human Reprod, 12, 1094, 10.1093/humrep/12.5.1094 Rai, 1996, Second-trimester pregnancy loss is associated with women activated protein C resistance, Br J Haematol, 92, 489, 10.1046/j.1365-2141.0000.d01-1465.x Grandone, 1997, Leiden is associated with repeated and recurrent fetal losses, Thromb Haemost, 77, 822, 10.1055/s-0038-1656060 Brenner, 1997, Activated protein C resistance can be associated with recurrent fetal loss, Br J Haematol, 97, 551, 10.1046/j.1365-2141.1997.882901.x Ridker, 1998, Leiden as a risk factor for recurrent pregnancy loss, Ann Intern Med, 128, 1000, 10.7326/0003-4819-128-12_Part_1-199806150-00007 Younis, 2000, Activated protein C resistance and Factor V Leiden mutation can be associated with first- as well as second-trimester recurrent pregnancy loss, Am J Reprod Immunol, 43, 31, 10.1111/j.8755-8920.2000.430106.x Foka, 2000, Leiden and prothrombin G20210A mutations, but not methyltetrahydrofolate reductase C677T, are associated with recurrent miscarriages, Hum Reprod, 15, 458, 10.1093/humrep/15.2.458 Dizon-Townson, 1997, The Factor V Leiden mutation is not a common cause of recurrent miscarriage, J Reprod Immunol, 34, 217, 10.1016/S0165-0378(97)00039-9 Pauer, 1998, Factor V Leiden and its relevance in patients with recurrent miscarriages [letter], Am J Obstet Gynecol, 178, 629, 10.1016/S0002-9378(98)70465-X Kutteh, 1998, Hypercoagulable state mutation analysis in white patients with early first trimester recurrent pregnancy loss, Fertil Steril, 71, 1048, 10.1016/S0015-0282(99)00133-8 Robert, 1996, Anticoagulant response to agkistrodon contrix venom (ACV test): a new global test to screen for defects in the anticoagulant protein C pathway, Thomb Haemost, 75, 562, 10.1055/s-0038-1650322 Robert, 1999, Screening for identified and unidentified protein C pathway defects by the agkistrodon contortrix venom test in consecutive patients, Am J Clin Pathol, 112, 233, 10.1093/ajcp/112.2.233 Preston, 1996, Increased fetal loss in women with heritable thrombophilia, Lancet, 348, 913, 10.1016/S0140-6736(96)04125-6 Meinardi, 1999, Increased risk for fetal loss in carriers of the Factor V Leiden mutation, Ann Intern Med, 130, 736, 10.7326/0003-4819-130-9-199905040-00013 Walker, 1997, Changes in activated protein C resistance during normal pregnancy, Am J Obstet Gynecol, 177, 162, 10.1016/S0002-9378(97)70456-3 McColl, 1999, Leiden, prothrombin 20210-A and the MTHFR C677 T mutations in childhood stroke, Thromb Haemost, 81, 690, 10.1055/s-0037-1614555 Souza, 1999, Leiden and Factor II G20210A mutations in patients with recurrent miscarriage, Hum Reprod, 14, 2448, 10.1093/humrep/14.10.2448